The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema

Dirican, Abuzer; Andaçoğlu, Oya; Johnson, R. R.; McGuire, Kandace P.; Mager, Lisa; Soran, Atilla

doi:10.1007/s00520-010-0888-8

Cited by 50 publications

(56 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Six of the nine studies reported on adverse events or discussed harm [6,[21][22][23][24]27]. Dirican et al [23] reported development of cellulitis in one participant in the LLLT group.…”

Section: Harmmentioning

confidence: 98%

See 1 more Smart Citation

Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Six of the nine studies reported on adverse events or discussed harm [6,[21][22][23][24]27]. Dirican et al [23] reported development of cellulitis in one participant in the LLLT group.…”

Section: Harmmentioning

confidence: 98%

“…This single-group pre-test/post-test study [23] investigated the effect of LLLT on 17 women with BCRL. All patients used compression garments or bandaging, and two used a pneumatic pump during the course of the study intervention.…”

Section: Dirican Et Al 2011mentioning

confidence: 99%

Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis

et al. 2014

View full text Add to dashboard Cite

show abstract

“…The proposed underlying mechanism is that LLLT increases the lymphatic drainage by stimulating the formation of new lymph vessels, by improving the lymphatic motricity, and by preventing the formation of fibrotic tissue [33][34][35][36].…”

Section: Lllt For the Management Of Bcrlmentioning

confidence: 99%

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

et al. 2016

View full text Add to dashboard Cite

Breast cancer is the most common cancer in women worldwide, with an incidence of 1.7 million in 2012. Breast cancer and its treatments can bring along serious side effects such as fatigue, skin toxicity, lymphedema, pain, nausea, etc. These can substantially affect the patients' quality of life. Therefore, supportive care for breast cancer patients is an essential mainstay in the treatment. Low-level light therapy (LLLT) also named photobiomodulation therapy (PBMT) has proven its efficiency in general medicine for already more than 40 years. It is a noninvasive treatment option used to stimulate wound healing and reduce inflammation, edema, and pain. LLLT is used in different medical settings ranging from dermatology, physiotherapy, and neurology to dentistry. Since the last twenty years, LLLT is becoming a new treatment modality in supportive care for breast cancer. For this review, all existing literature concerning the use of LLLT for breast cancer was used to provide evidence in the following domains: oral mucositis (OM), radiodermatitis (RD), lymphedema, chemotherapy-induced peripheral neuropathy (CIPN), and osteonecrosis of the jaw (ONJ). The findings of this review suggest that LLLT is a promising option for the management of breast cancer treatment-related side effects. However, it still remains important to define appropriate treatment and irradiation parameters for each condition in order to ensure the effectiveness of LLLT.

show abstract

“…It is backed by longstanding clinical experience. Other modalities such as low-level laser therapy (LLLT) and surgical approaches have demonstrated beneficial effects for selected patients with lymphedema, and could be considered as an adjunct therapy alongside standard treatment methods [8,9]. Intermittent pneumatic compression pump (IPC) devices are pneumatic cuffs connected to pumps that mimic the naturally occurring pump effect of muscles contracting around peripheral lymphatics [10].…”

Section: Introductionmentioning

confidence: 99%

Intermittent Pneumatic Compression Pump for Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

et al. 2014

View full text Add to dashboard Cite

Background: Breast cancer-related lymphedema (BCRL) is a common complication after the treatment of breast cancer. The objective of this study was to determine whether the use of an intermittent pneumatic pump (IPC) could manage lymphedema effectively. Methods: We searched PubMed, EMBASE, and the Cochrane Library for related trials to compare the percent of volume reduction and subjective symptoms. Results: 7 randomized controlled trials, with 287 patients, were included. Results showed that the use of the IPC could alleviate lymphedema, but no significant difference between routine management of lymphedema with or without pneumatic pump existed. Conclusion: Current trials fail to show the effectiveness of the addition of an IPC to the routine management of BCRL.

show abstract

The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema

Cited by 50 publications

References 17 publications

Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis

Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis

The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature

Intermittent Pneumatic Compression Pump for Breast Cancer-Related Lymphedema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Contact Info

Product

Resources

About